← All stocks

Xilio Therapeutics, Inc.

XLO No buying or selling
CIK 0001840233 #4621 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

6 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
GILEAD SCIENCES, INC. entity
10% owner
9,105,451
$80.04M
+24.0%
Russo Rene
PRESIDENT AND CEO
325,422
$2.86M
+62.2%
Luptakova Katarina
CHIEF MEDICAL OFFICER
33,250
$292.27K
Frankenfield Christopher James
Chief Financial Officer
24,766
$217.69K
Shannon James Samuel
Director
10,000
$87.90K
Brennan Kevin M.
SVP, FINANCE AND ACCOUNTING
6,371
$56.00K

No percentages here. This company's share count has moved by a factor of 9.1 over the window, from 5,782,511 to 52,500,328 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 25 Oct 2021